Meeting
2024 ASCO Genitourinary Cancers Symposium
Association of DAZL expression with risk of recurrence in clinical stage 1 testicular germ cell tumors.
Authors
Alok Tewari
Dana-Farber Cancer Institute, Boston, MA
Alok Tewari , Anis Hamid , Jiaming Huang , Caiwei Zhong , Wanling Xie , Emily Rothmann , Peter Nicholls , Nathan Walk , Iva Brcic , Angelika Terbuch , Eliezer Mendel Van Allen , Christopher Sweeney
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 523)
DOI
10.1200/JCO.2024.42.4_suppl.523
Abstract #
523
Poster Bd #
M3
Abstract Disclosures
Similar Posters
Poster
2016 Genitourinary Cancers Symposium
Optimization of an imaging protocol for stage I seminoma surveillance based on variations in relapse location over time.
First Author: Andrew McPartlin
Poster
2023 ASCO Genitourinary Cancers Symposium
A multicenter prospective validation study of the 3-cm cut-off in stage I seminoma (S3MI-PT).
First Author: Mario Fontes-Sousa
Poster
2014 Genitourinary Cancers Symposium
An audit of adjuvant carboplatin in patients with stage I testicular seminoma (Anglian Germ Cell Cancer Group, UK).
First Author: Amy Kwan
Poster
2014 Genitourinary Cancers Symposium
Craniocaudal retroperitoneal node length as a risk factor for relapse from clinical stage I testicular germ cell tumor.
First Author: Stephanie Anne Holler Howard